Cleveland Heart Lab closed on a Series B financing round that totals $18.4 million. The money was provided by Excel Venture Management, Healthcare Ventures, and existing investors. Executives at Cleve- land Heart Lab said the new funds will be used to further promote its proprietary diagnostic tests that assess risk of cardiovascular disease. The company …
September 6, 2011 “Intelligence: Late Breaking Lab News” Read More »
